Agenus Inc. (AGEN): Price and Financial Metrics

Agenus Inc. (AGEN): $0.70

0.04 (+6.01%)

POWR Rating

Component Grades








Add AGEN to Watchlist
Sign Up

Industry: Biotech




#208 of 339

in industry

AGEN Price/Volume Stats

Current price $0.70 52-week high $3.07
Prev. close $0.66 52-week low $0.61
Day low $0.63 Volume 19,825,500
Day high $0.72 Avg. volume 5,264,368
50-day MA $0.91 Dividend yield N/A
200-day MA $1.43 Market Cap 267.05M

AGEN Stock Price Chart Interactive Chart >


  • AGEN scores best on the Growth dimension, with a Growth rank ahead of 68.17% of US stocks.
  • AGEN's strongest trending metric is Momentum; it's been moving down over the last 177 days.
  • AGEN ranks lowest in Momentum; there it ranks in the 4th percentile.

AGEN Stock Summary

  • AGENUS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 5.73% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -4.52 for AGENUS INC; that's greater than it is for just 3.59% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AGEN comes in at -55.2% -- higher than that of merely 9.84% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AGENUS INC are CTMX, VTGN, EIGR, CRBU, and DBVT.
  • Visit AGEN's SEC page to see the company's official filings. To visit the company's web site, go to

AGEN Valuation Summary

  • AGEN's price/earnings ratio is -1.2; this is 104.94% lower than that of the median Healthcare stock.
  • Over the past 243 months, AGEN's price/sales ratio has gone down 80.8.

Below are key valuation metrics over time for AGEN.

Stock Date P/S P/B P/E EV/EBIT
AGEN 2023-11-03 3.2 -3.4 -1.2 -1.3
AGEN 2023-11-02 3.2 -3.5 -1.2 -1.3
AGEN 2023-11-01 3.2 -3.4 -1.2 -1.3
AGEN 2023-10-31 3.1 -3.3 -1.2 -1.2
AGEN 2023-10-30 3.0 -3.2 -1.1 -1.2
AGEN 2023-10-27 3.0 -3.2 -1.1 -1.2

AGEN Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at -52.01%.
  • Its year over year revenue growth rate is now at 265.6%.
  • The 2 year price growth rate now stands at -36.88%.
Over the past 33 months, AGEN's revenue has gone down $60,148,000.

The table below shows AGEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 89.9 -150.962 -214.704
2022-06-30 320.082 12.602 18.07
2022-03-31 309.886 0.498 -18.786
2021-12-31 295.665 10.145 -24.137
2021-09-30 306.667 -2.518 3.767
2021-06-30 68.545 -165.517 -225.937

AGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AGEN has a Quality Grade of C, ranking ahead of 55.26% of graded US stocks.
  • AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks.
  • COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN.

The table below shows AGEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.324 0.949 8.194
2021-03-31 0.404 0.959 5.948
2020-12-31 0.449 0.973 3.708
2020-09-30 0.504 0.983 2.706
2020-06-30 0.555 0.993 2.612
2020-03-30 0.476 1.000 2.580

AGEN Price Target

For more insight on analysts targets of AGEN, see our AGEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.00 Average Broker Recommendation 1.17 (Strong Buy)

Agenus Inc. (AGEN) Company Bio

Agenus Inc. engages in discovering and developing innovative treatments for patients with cancer and other diseases. The company was founded in 1994 and is based in Lexington, Massachusetts.

AGEN Latest News Stream

Event/Time News Detail
Loading, please wait...

AGEN Latest Social Stream

Loading social stream, please wait...

View Full AGEN Social Stream

Latest AGEN News From Around the Web

Below are the latest news stories about AGENUS INC that investors may wish to consider to help them evaluate AGEN as an investment opportunity.

Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance

Avita's (RCEL) stock declines 19% after the company lowered its total revenue guidance for 2023.

Yahoo | November 22, 2023

Repare Therapeutics (RPTX) Rises 34% in a Week: Here's Why

Repare Therapeutics (RPTX) rises 34% in a week after announcing plans to begin clinal-stage development of two additional candidates, RP-1664 and RP-3467, in 2024 in several solid tumor indications.

Yahoo | November 20, 2023

Rainbows and Unicorns: Agenus Inc. (NASDAQ:AGEN) Analysts Just Became A Lot More Optimistic

Agenus Inc. ( NASDAQ:AGEN ) shareholders will have a reason to smile today, with the analysts making substantial...

Yahoo | November 9, 2023

Agenus Inc (AGEN) Reports Q3 2023 Results: Revenue of $24.3 Million and Net Loss of $64.5 Million

Key Highlights Include Promising Clinical Data and Anticipated Regulatory Filings

Yahoo | November 7, 2023

Agenus Reports Third Quarter 2023 Results

LEXINGTON, Mass., November 07, 2023--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the third quarter 2023. Agenus executives will host a conference call and webcast at 9:00 a.m. ET to discuss the results and to provide a corporate update.

Yahoo | November 7, 2023

Read More 'AGEN' Stories Here

AGEN Price Returns

1-mo -11.92%
3-mo -49.28%
6-mo -56.25%
1-year -73.38%
3-year -81.13%
5-year -70.95%
YTD -70.83%
2022 -25.47%
2021 1.26%
2020 -21.87%
2019 71.01%
2018 -26.99%

Continue Researching AGEN

Here are a few links from around the web to help you further your research on Agenus Inc's stock as an investment opportunity:

Agenus Inc (AGEN) Stock Price | Nasdaq
Agenus Inc (AGEN) Stock Quote, History and News - Yahoo Finance
Agenus Inc (AGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!